相关实验视频
Updated: Jan 14, 2026

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
3.4K
在内血管中风治疗期间,阿司匹林和未分离的肝素对白质病变效应的修饰
Laura M van Poppel1,2,3,4, Lucas de Vries5,6,7,8,9, Mahsa Mojtahedi5,6,7,8
1Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, The Netherlands. l.m.vanpoppel@amsterdamumc.nl.
Insights into imaging
|October 22, 2025
概括
白质病变体积改变了阿司匹林的作用.
科学领域:
- 神经学 神经学
- 干预神经病学 干预神经病学
- 神经成像是一种神经成像.
背景情况:
- 急性缺血性中风的内血管治疗包括周围手术用阿司匹林或肝素.
- 这些药物增加了症状性内出血 (sICH) 的风险,但没有改善结果.
- 白质病变 (WMLs) 与较高的SICH风险和较差的中风结果有关.
研究的目的:
- 调查WML体积是否影响内血管治疗期间阿司匹林或肝素的影响.
- 分析WML对中风患者的sICH风险和功能结果的影响.
主要方法:
- 对MR CLEAN-MED试验数据的后期分析.
- 在基线CT扫描上使用深度学习进行自动化WML体积细分.
- 多变量逻辑回归用于评估治疗效应和修改.
主要成果:
- WML体积显著改变了阿司匹林对SICH风险的影响 (p=0.01).
- 随着WML体积的增加,阿司匹林的SICH风险下降;在大型WML病例中没有显著的风险.
- 肝素对结果的影响没有受到WML体积的改变.
结论:
- 在内血管中风治疗中,WML体积改变了阿司匹林对SICH风险的影响.
- 增加WML体积可以降低阿司匹林相关的SICH风险.
- 没有WML患者小组显示周围手术用阿司匹林或肝素有明显的益处.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Venous Thrombosis III: Interprofessional Care
278
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
278
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K

